The activation of Axl may promote tumor invasiveness and drug resistance by inhibiting the host immune response, by inducing the epithelial–mesenchymal transition phenotype or suppressing the apoptosis of malignant cells [34,36,37,38]. Here, AXL is linked to neoplasm.